CSV Manager, Quality Systems Technology (QST) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Corcept Therapeutics · 6 hours ago

CSV Manager, Quality Systems Technology (QST)

Corcept Therapeutics is a leader in the research and development of cortisol modulators. They are seeking a Computer Systems Validation (CSV) Manager to manage validated systems, compliance initiatives, and system enhancements, ensuring that systems supporting GxP activities are reliable and compliant.

BiotechnologyMedicalPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Drive continuous improvement initiatives for Corcept’s Quality Management System (QMS) and support enhancements to validated GxP systems such as Veeva, Argus, SAS and ComplianceWire
Collaborate with IT and QA teams to enforce requirements for validated systems
Monitor and perform periodic system reviews, identify compliance gaps, and implement corrective actions
Prepare for regulatory inspections and support audits by ensuring validated systems meet compliance requirements (GxP, 21 CFR Part 11, and EU Annex 11 requirements)
Support Inspection Remediation activities and CAPA closure
Evaluate the impact of system updates, patches, and configuration changes, ensuring compliance with GxP regulations and data integrity principles and implement the update
Collaborate with cross-functional teams to optimize workflows, reporting capabilities, and system usability to meet business and compliance needs
Coordinate vendor release activities and assist in resolving system issues with software and consulting vendors
Develop GxP SOPs and support training efforts for personnel on those SOPs and related regulations

Qualification

GxP systemsQuality Management SystemComputer System ValidationVeevaSASComplianceWireGxP SOPsRegulatory complianceContinuous improvementCustomer-focusedTeam collaboration

Required

Drive continuous improvement initiatives for Corcept's Quality Management System (QMS) and support enhancements to validated GxP systems such as Veeva, Argus, SAS and ComplianceWire
Collaborate with IT and QA teams to enforce requirements for validated systems
Monitor and perform periodic system reviews, identify compliance gaps, and implement corrective actions
Prepare for regulatory inspections and support audits by ensuring validated systems meet compliance requirements (GxP, 21 CFR Part 11, and EU Annex 11 requirements)
Support Inspection Remediation activities and CAPA closure
Evaluate the impact of system updates, patches, and configuration changes, ensuring compliance with GxP regulations and data integrity principles and implement the update
Collaborate with cross-functional teams to optimize workflows, reporting capabilities, and system usability to meet business and compliance needs
Coordinate vendor release activities and assist in resolving system issues with software and consulting vendors
Develop GxP SOPs and support training efforts for personnel on those SOPs and related regulations
Thorough understanding of quality systems that support internal GxP activities for pre-clinical, clinical, and commercial products
Proficiency in the use of GxP-validated systems such as Veeva (eTMF, Quality, and RIM), SAS, and ComplianceWire
Hands-on experience with QMS system implementations or other GXP systems
Experience developing GxP SOPs and training personnel regarding those SOPs and the corresponding government regulations
Customer-focused and able to prioritize with competing priorities
8+ years' experience in the development and maintenance of quality systems in clinical and commercial-stage pharmaceutical companies
Deep knowledge of ICH Q10 & GAMP 5, 21 CFR Part 11 and Annex 11
Familiarity with risk-based computer system validation (CSV/CSA) strategies

Company

Corcept Therapeutics

twittertwittertwitter
company-logo
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.

Funding

Current Stage
Public Company
Total Funding
$119.09M
Key Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M

Leadership Team

leader-logo
Roberto Vieira
President, Oncology
linkedin
leader-logo
Yuan Xu
Associate Director, Statistical Programming
linkedin
Company data provided by crunchbase